INGN News and Press, Inogen Inc From 05/05/22

– Q1 2022 Total Revenue of $80.4 million – Inogen, Inc. (NASDAQ: INGN ), a medical technology company offering innovative respiratory products for use in the homecare setting, today reported financial results for the three months ended March 31, 202...

Inogen, Inc . (Nasdaq: INGN ), a medical technology company offering innovative respiratory products for use in the homecare setting, announced that it will release first quarter 2022 financial results after market close on Thursday, May 5, 2022. The Company will host a correspo...

Supply chain issues have hit Inogen hard, undermining the company's ability to ship to demand and driving some share loss despite healthy underlying demand trends. Management has redesigned its motherboards to use the chips it can find, but supply challenges may not meaningfully resol...

Inogen, Inc. (NASDAQ: INGN ), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that the Company’s management will be participating in the 21 st Annual Needham Virtual Healthcare Conference. Inog...

Inogen (NASDAQ:INGN) has appointed Kristin Caltrider as EVP & Chief Financial Officer, effective March 21, 2022. Ms. Caltrider joins Inogen from Quidel, where she most recently served as Vice President of Finance since June 2014. She succeeds Mike Sergesketter, who joined Inogen as interi...

Inogen, Inc. (NASDAQ: INGN ), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced the appointment of Kristin Caltrider as EVP & Chief Financial Officer, effective March 21, 2022. Ms. Caltrider succeeds Mike S...

The following slide deck was published by Inogen, Inc. in conjunction with their 2021 Q4 earnings call. For further details see: Inogen, Inc. 2021 Q4 - Results - Earnings Call Presentation

Inogen (INGN +5.2%) rose pre-market following its Q4 results on Feb. 24 post market. Q4 total revenue rose 3.3% Y/Y to $76.4M, missing analysts' estimates of $76.60M. The increase was mainly driven by improved average selling prices, sustained demand, and the reduced impact of the COVID-19 pa...

Inogen, Inc. (INGN) Q4 2021 Earnings Conference Call February 24, 2022 05:00 PM ET Company Participants Jason Somer - General Counsel Nabil Shabshab - Chief Executive Officer Mike Sergesketter - Chief Financial Officer Conference Call Participants Robbie Marcus - JPMorgan Brett Fishbin - KeyB...

Inogen press release (NASDAQ:INGN): Q4 GAAP EPS of -$1.01 misses by $0.30. Revenue of $76.4M (+3.3% Y/Y) misses by $0.2M. For further details see: Inogen GAAP EPS of -$1.01 misses by $0.30, revenue of $76.4M misses by $0.2M